PBLA OTC
Panbela Therapeutics, Inc.
1W: +0.0%
1M: +11000.0%
3M: +122.0%
YTD: -15.3%
1Y: -77.8%
3Y: -100.0%
5Y: -100.0%
$0.01
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$25M
-65.3% ▼
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$25M
-58.4% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$10K
+0.0% ▲
Net Change in Cash
$1M
+112.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$6M | -$5M | -$10M | -$35M | -$25M |
| Depreciation & Amort. | $2M | $114K | $0 | $0 | $0 |
| Stock-Based Comp. | $1M | $1M | $1M | $1M | $823K |
| Change in Working Capital | $188K | -$188K | $2M | $559K | -$647K |
| Other Non-Cash Items | $2M | -$103K | $0 | $18M | -$162K |
| Operating Cash Flow | -$3M | -$4M | -$7M | -$15M | -$25M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | -$660K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $4K | $400K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | -$540K | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$540K | -$656K | $400K |
| — Financing Activities — | |||||
| Net Debt Issuance | $624K | -$757K | $0 | $0 | -$2M |
| Stock Repurchased | $0 | $0 | $0 | $0 | -$10K |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $120K | $1M | $5K | $5M |
| Financing Cash Flow | $4M | $10M | $10M | $5M | $26M |
| Net Change in Cash | $1M | $7M | $3M | -$11M | $1M |
| Cash End of Period | $2M | $9M | $12M | $1M | $3M |
| Free Cash Flow | -$3M | -$4M | -$7M | -$16M | -$25M |